Impact of chronic total occlusion on prognosis in cardiogenic shock due to unprotected left main coronary artery
Mateusz Tajstra1, Leszek Bryniarski2, Kamil Bujak3
13rd Department of Cardiology, Silesian Centre for Heart Diseases, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Zabrze, Poland. mateusztajstra@wp.pl.
Kardiologia Polska
|March 17, 2024
Summary
The presence of chronic total occlusions (CTOs) in patients experiencing cardiogenic shock (CS) from unprotected left main culprit lesion-related acute myocardial infarction (ULMCL-related AMI) is linked to a significantly higher 12-month mortality rate, even after treatment.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Myocardial Infarction Research
Background:
- Cardiogenic shock (CS) from unprotected left main culprit lesion-related acute myocardial infarction (ULMCL-related AMI) carries a high mortality rate despite medical advancements.
- Chronic total occlusions (CTOs) are frequently observed in patients with ULMCL-related AMI and CS.
Purpose of the Study:
- To investigate the association between the presence of CTO and 12-month mortality in patients with CS due to ULMCL-related AMI.
Main Methods:
- A prospective registry study (Polish Registry of Acute Coronary Syndromes - PL-ACS) included 250 patients with AMI-related CS and ULMCL treated with percutaneous coronary intervention (PCI).
- Patients were stratified into groups with (+CTO) and without (-CTO) at least one major coronary artery CTO.
- The primary endpoint was all-cause death at 12 months.
Main Results:
- 24% of patients had at least one CTO (+CTO group).
- 12-month mortality was significantly higher in the +CTO group (85%) compared to the -CTO group (69.8%; P log-rank = 0.03).
- After multivariable adjustment, CTO presence remained a significant predictor of increased 12-month mortality (HR, 1.423; P = 0.034).
Conclusions:
- In patients with CS due to ULMCL-related AMI undergoing PCI, the presence of CTO is associated with a worse 12-month prognosis.
- CTO is an independent predictor of mortality in this high-risk patient cohort.


